212 related articles for article (PubMed ID: 28937683)
1. A vitronectin-derived peptide reverses ovariectomy-induced bone loss via regulation of osteoblast and osteoclast differentiation.
Min SK; Kang HK; Jung SY; Jang DH; Min BM
Cell Death Differ; 2018 Feb; 25(2):268-281. PubMed ID: 28937683
[TBL] [Abstract][Full Text] [Related]
2. A Vitronectin-Derived Peptide Restores Ovariectomy-Induced Bone Loss by Dual Regulation of Bone Remodeling.
Kang HK; Park CY; Jung SY; Jo SB; Min BM
Tissue Eng Regen Med; 2022 Dec; 19(6):1359-1376. PubMed ID: 36207661
[TBL] [Abstract][Full Text] [Related]
3. Pitavastatin prevents ovariectomy-induced osteoporosis by regulating osteoclastic resorption and osteoblastic formation.
Cheon YH; Lee CH; Kim S; Park GD; Kwak SC; Cho HJ; Kim JY; Lee MS
Biomed Pharmacother; 2021 Jul; 139():111697. PubMed ID: 34243614
[TBL] [Abstract][Full Text] [Related]
4. WHI-131 Promotes Osteoblast Differentiation and Prevents Osteoclast Formation and Resorption in Mice.
Cheon YH; Kim JY; Baek JM; Ahn SJ; Jun HY; Erkhembaatar M; Kim MS; Lee MS; Oh J
J Bone Miner Res; 2016 Feb; 31(2):403-15. PubMed ID: 26255791
[TBL] [Abstract][Full Text] [Related]
5. The TRPV1 ion channel antagonist capsazepine inhibits osteoclast and osteoblast differentiation in vitro and ovariectomy induced bone loss in vivo.
Idris AI; Landao-Bassonga E; Ralston SH
Bone; 2010 Apr; 46(4):1089-99. PubMed ID: 20096813
[TBL] [Abstract][Full Text] [Related]
6. Jiangu formula: A novel osteoclast-osteoblast coupling agent for effective osteoporosis treatment.
Xu H; Lu X; Li M; Huang X; Yao N; Gan H; Huang X; Zhao Z; Hu Z; Zhao X; Lai Y; Li M; Chen S; Chen Y; Huang D
Phytomedicine; 2024 Jun; 128():155501. PubMed ID: 38471318
[TBL] [Abstract][Full Text] [Related]
7. Bortezomib prevents ovariectomy-induced osteoporosis in mice by inhibiting osteoclast differentiation.
Kim SH; Kim MO; Kim HJ; Neupane S; Kim HJ; Lee JH; Kim HH; Kim JY; Lee Y
J Bone Miner Metab; 2018 Sep; 36(5):537-546. PubMed ID: 29027021
[TBL] [Abstract][Full Text] [Related]
8. Two novel peptides from ark shell protein stimulate osteoblast differentiation and rescue ovariectomy-induced bone loss.
Oh Y; Ahn CB; Hyung JH; Je JY
Toxicol Appl Pharmacol; 2019 Dec; 385():114779. PubMed ID: 31697996
[TBL] [Abstract][Full Text] [Related]
9. Suppression of NF-kappaB increases bone formation and ameliorates osteopenia in ovariectomized mice.
Alles N; Soysa NS; Hayashi J; Khan M; Shimoda A; Shimokawa H; Ritzeler O; Akiyoshi K; Aoki K; Ohya K
Endocrinology; 2010 Oct; 151(10):4626-34. PubMed ID: 20810563
[TBL] [Abstract][Full Text] [Related]
10. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
11. Streptococcus gordonii induces bone resorption by increasing osteoclast differentiation and reducing osteoblast differentiation.
Park OJ; Kim J; Kim HY; Kwon Y; Yun CH; Han SH
Microb Pathog; 2019 Jan; 126():218-223. PubMed ID: 30414445
[TBL] [Abstract][Full Text] [Related]
12. Liver X receptors orchestrate osteoblast/osteoclast crosstalk and counteract pathologic bone loss.
Kleyer A; Scholtysek C; Bottesch E; Hillienhof U; Beyer C; Distler JH; Tuckermann JP; Schett G; Krönke G
J Bone Miner Res; 2012 Dec; 27(12):2442-51. PubMed ID: 22806960
[TBL] [Abstract][Full Text] [Related]
13. A novel anti-osteoporotic agent that protects against postmenopausal bone loss by regulating bone formation and bone resorption.
Yang YT; Meng JH; Hu B; Ma CY; Zhao CC; Teng WS; Hong JQ; Li SH; Jiang GY; Wang C; Zhou CH; Yan SG
Life Sci; 2018 Sep; 209():409-419. PubMed ID: 30096387
[TBL] [Abstract][Full Text] [Related]
14. Emodin regulates bone remodeling by inhibiting osteoclastogenesis and stimulating osteoblast formation.
Kim JY; Cheon YH; Kwak SC; Baek JM; Yoon KH; Lee MS; Oh J
J Bone Miner Res; 2014 Jul; 29(7):1541-53. PubMed ID: 25832436
[TBL] [Abstract][Full Text] [Related]
15. Harmine, a β-carboline alkaloid, inhibits osteoclast differentiation and bone resorption in vitro and in vivo.
Yonezawa T; Hasegawa S; Asai M; Ninomiya T; Sasaki T; Cha BY; Teruya T; Ozawa H; Yagasaki K; Nagai K; Woo JT
Eur J Pharmacol; 2011 Jan; 650(2-3):511-8. PubMed ID: 21047508
[TBL] [Abstract][Full Text] [Related]
16. The bone regenerative effects of fucosterol in in vitro and in vivo models of postmenopausal osteoporosis.
Lee DG; Park SY; Chung WS; Park JH; Shin HS; Hwang E; Kim IH; Yi TH
Mol Nutr Food Res; 2014 Jun; 58(6):1249-57. PubMed ID: 24604889
[TBL] [Abstract][Full Text] [Related]
17. Pilose antler peptide potentiates osteoblast differentiation and inhibits osteoclastogenesis via manipulating the NF-κB pathway.
Liu G; Ma C; Wang P; Zhang P; Qu X; Liu S; Zhai Z; Yu D; Gao J; Liang J; Dai W; Zhou L; Xia M; Yang H
Biochem Biophys Res Commun; 2017 Sep; 491(2):388-395. PubMed ID: 28733032
[TBL] [Abstract][Full Text] [Related]
18. Poligoni Multiflori Radix enhances osteoblast formation and reduces osteoclast differentiation.
Han SY; Lee KH; Kim YK
Int J Mol Med; 2018 Jul; 42(1):331-345. PubMed ID: 29620250
[TBL] [Abstract][Full Text] [Related]
19. A novel small-molecule PPI inhibitor targeting integrin αvβ3-osteopontin interface blocks bone resorption in vitro and prevents bone loss in mice.
Park D; Park CW; Choi Y; Lin J; Seo DH; Kim HS; Lee SY; Kang IC
Biomaterials; 2016 Aug; 98():131-42. PubMed ID: 27187277
[TBL] [Abstract][Full Text] [Related]
20. Quinoxaline derivative of oleanolic acid inhibits osteoclastic bone resorption and prevents ovariectomy-induced bone loss.
Zhao Y; Huai Y; Jin J; Geng M; Li JX
Menopause; 2011 Jun; 18(6):690-7. PubMed ID: 21228726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
